Singapore markets closed

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2100-0.0300 (-0.93%)
As of 09:39AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
460,829
468,059
338,298
260,981
193,449
Cost of revenue
110,496
114,199
87,319
75,948
68,808
Gross profit
350,333
353,860
250,979
185,033
124,641
Operating expenses
Research development
36,005
30,742
20,086
14,799
10,742
Selling general and administrative
265,806
250,200
203,478
199,693
161,961
Total operating expenses
301,811
280,942
223,564
214,492
172,703
Operating income or loss
48,522
72,918
27,415
-29,459
-48,062
Interest expense
3,802
7,236
11,279
8,996
10,853
Total other income/expenses net
-1,935
-1,896
2,343
-1,849
-5,896
Income before tax
42,785
63,786
18,479
-40,304
-64,747
Income tax expense
-29,318
-31,116
530
150
84
Income from continuing operations
72,103
94,902
17,949
-40,454
-64,831
Net income
72,103
94,902
17,949
-40,454
-64,831
Net income available to common shareholders
72,103
94,902
17,949
-41,099
-64,831
Basic EPS
-
0.74
0.17
-0.44
-0.94
Diluted EPS
-
0.71
0.16
-0.44
-0.94
Basic average shares
-
128,331
107,738
92,840
69,318
Diluted average shares
-
133,663
111,361
92,840
69,318
EBITDA
-
87,698
37,226
-21,877
-46,916